Coen received his MSc in Pharmaceutical Sciences from Leiden University, Netherlands and a PhD degree focusing on quantitative pharmacology in oncology from Utrecht University, Netherlands. During his PhD Coen also registered as a board-certified clinical pharmacologist. Coen then worked as postdoctoral fellow at Leiden University focusing on PBPK modeling applied to antimicrobial drugs. His current research interests are the use of omics approaches to inform PKPD and QSP based models, applied to cardiotoxicity, oncology and infectious diseases.